相关实验视频

Updated: Jun 26, 2025

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

抗体-药物结合物:在癌症治疗中,这是一个有希望的突破

Swapnali Parit¹, Ajit Manchare¹, Amol D Gholap²

¹Institute of Chemical Technology, Marathwada Campus, Jalna 431203, Maharashtra, India.

International journal of pharmaceutics

|May 16, 2024

概括

抗体-药物联合体 (ADC) 通过将细胞毒药物向瘤细胞,提供精确的癌症治疗. 在ADC设计中的创新对于克服阻力和提高效率至关重要.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
生物技术是生物技术.

背景情况:

抗体-药物合物 (ADC) 是癌症治疗的向治疗方法.
ADCs选择性地向癌细胞传递细胞毒性有效载荷,最大限度地减少非目标效应.
药物耐药性和癌症异质性等挑战需要进一步开发ADC.

研究的目的:

批判性地分析ADC的功能机制.
为突出ADC开发抗体工程的进步.
审查ADCs的临床进展和批准的配方.

主要方法:

分析ADC功能机制,包括抗体-链接器-有效载荷相互作用.
检查抗体工程方面的进展,以提高ADC的特异性和功效.
临床试验和批准的ADC配方的审查.

主要成果:

在癌症药物输送过程中,ADCs表现出高精度和特异性.
抗体工程方面的创新正在导致更强效和更有选择性的ADC.
在临床ADC开发方面取得了重大进展,有几种已批准的疗法.

结论:

ADCs是针对性癌症治疗的重要工具,提供了显著的优势.
对分子设计的持续创新对于解决耐药性和改善患者治疗结果至关重要.
对ADC机制和临床应用的进一步研究将增强其治疗潜力.

关键词:

抗体与药物的结合物.抗体与药物的结合.癌症治疗治疗癌症治疗药物与抗体的比率药物与抗体的比率链接分子分子链接分子单克隆抗体是一种单克隆抗体.实用载荷的使用量

更多相关视频

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Antibody Actions

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...

Phase II Conjugation Reactions: Overview

Phase II Conjugation Reactions: Overview

Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...